Drug – bio-affecting and body treating compositions – Fermentate of unknown chemical structure – Having a known elemental analysis
Patent
1987-02-19
1988-06-07
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Fermentate of unknown chemical structure
Having a known elemental analysis
424120, 435171, A61K 3570, C12P 102
Patent
active
047495715
ABSTRACT:
A physiologically-active novel substance "aldostatin" having an estimated molecular formula of C.sub.20 H.sub.20 N.sub.2 O.sub.8 is produced by culturing an aldostatin-producing microorganism of the Pseudeurotium, for example, the Pseudeurotium zonatum M4109 strain. Aldostatin inhibits the aldose reductase activity and as a consequence, avoids abnormal accumulation of sorbitol, galactitol, etc. It is therefore effective for the treatment of chronic complications such as cataract, retinopathy and neuropathy caused by diabetes renalis.
REFERENCES:
Chemical Abstracts, Registry No. 13200-86-7 (N-formyltyrosin).
Asahi Akira
Takada Masaki
Yaginuma Satoshi
Goldberg Jerome D.
Toyo Jozo Co., Ltd.
LandOfFree
Physiologically-active novel substance "Aldostatin" and producti does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Physiologically-active novel substance "Aldostatin" and producti, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Physiologically-active novel substance "Aldostatin" and producti will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-844010